114
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Activity of Caffeic Acid Phenethyl Ester in Caenorhabditis Elegans

, , , , , , , , & show all
Pages 2033-2046 | Received 21 Apr 2016, Accepted 18 Aug 2016, Published online: 14 Oct 2016
 

Abstract

Aim: Caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE), the major constituent of propolis, is able to increase the survival of the nematode Caenorhabditis elegans after infection with the fungal pathogen Candida albicans. Results: CAPE increases the expression of several antimicrobial proteins involved in the immune response to C. albicans. Structural derivatives of CAPE were synthesized to identify structure–activity relationships and decrease metabolic liability, ultimately leading to a compound that has similar efficacy, but increased in vivo stability. The CED-10(Rac-1)/PAK1 pathway was essential for immunomodulation by CAPE and was a critical component involved in the immune response to fungal pathogens. Conclusion:Caenorhabditis elegans is an efficient heterologous host to evaluate immunomodulatory compounds and identify components of the pathway(s) involved in the mode of action of compounds.

Acknowledgements

The authors would like to thank R Pukkila-Worley for guidance and oligos regarding the expression studies. The authors would like to thank S Johnston for analytical chemistry support and Sai Life Sciences for their analog synthesis support.

Financial & competing interests disclosure

This research was made possible by NIH funding from the National Institute of Allergy and Infectious Diseases P01 AI083214 to E Mylonakis and National Cancer Institute RC2 CA148399 to AN Koehler, and a grant from the Rhode Island Medical Foundation to JJ Coleman. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

This research was made possible by NIH funding from the National Institute of Allergy and Infectious Diseases P01 AI083214 to E Mylonakis and National Cancer Institute RC2 CA148399 to AN Koehler, and a grant from the Rhode Island Medical Foundation to JJ Coleman. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.